Chapter 13 – Personalized Medicine

Previous chapters of this book provided the background and history of medical information storage, and availability. Various systems of coding and quality control of data were presented. This chapter presents the full rationale for using this digital information for building “smart” decisioning systems. It ends with presentation of a number of challenges in medical information for merging group-based medical treatment with personalized medical care.

[1]  D. Brizel,et al.  Head and Neck Cancer as a Model for Advances in Imaging Prognosis, Early Assessment, and Posttherapy Evaluation , 2011, Cancer journal.

[2]  J. Ioannidis,et al.  Meta-analysis methods for genome-wide association studies and beyond , 2013, Nature Reviews Genetics.

[3]  J. T. Jørgensen,et al.  New era of personalized medicine: a 10-year anniversary. , 2009, The oncologist.

[4]  Ju-Hong Lee,et al.  New Morphological Features for Grading Pancreatic Ductal Adenocarcinomas , 2013, BioMed research international.

[5]  Joel Gelernter,et al.  The Role and Challenges of Exome Sequencing in Studies of Human Diseases , 2013, Front. Genet..

[6]  Ipek Oguz,et al.  Fully automated rodent brain MR image processing pipeline on a Midas server: from acquired images to region-based statistics , 2013, Front. Neuroinform..

[7]  F. Heller,et al.  GENETICS/GENOMICS AND DRUG EFFECTS , 2013, Acta clinica Belgica.

[8]  Luigi Atzori,et al.  Metabolomics in the developing infant , 2013, Current opinion in pediatrics.

[9]  B. Jackson,et al.  Chronic Obstructive Pulmonary Disease and SocioEconomic Status: a Systematic Review , 2012, COPD.

[10]  Gerald W. Hart,et al.  Glycomics: Building Upon Proteomics to Advance Glycosciences , 2013, Molecular & Cellular Proteomics.

[11]  Tamás Nepusz,et al.  Understanding how adherence goals promote adherence behaviours: a repeated measure observational study with HIV seropositive patients , 2012, BMC Public Health.

[12]  David A Rasko,et al.  The human microbiome: from symbiosis to pathogenesis. , 2013, Annual review of medicine.

[13]  Reinhard Schneider,et al.  Unraveling genomic variation from next generation sequencing data , 2013, BioData Mining.

[14]  Lei Zhang,et al.  Pharmacogenomics: historical perspective and current status. , 2013, Methods in molecular biology.

[15]  Christopher H Wade,et al.  Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice. , 2013, Annual review of genomics and human genetics.

[16]  Nicola Luigi Bragazzi,et al.  From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and “augmented” medicine: some considerations on Salvatore Iaconesi’s clinical story , 2013, Patient preference and adherence.

[17]  Brian V. Nahed,et al.  Socioeconomic Status Correlates with the Prevalence of Advanced Coronary Artery Disease in the United States , 2012, PloS one.

[18]  Leroy Hood,et al.  Systems Approaches to Biology and Disease Enable Translational Systems Medicine , 2012, Genom. Proteom. Bioinform..

[19]  J. Clemente,et al.  Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice , 2013, Science.

[20]  Lora E. Fleming,et al.  Potential Changes in Disease Patterns and Pharmaceutical Use in Response to Climate Change , 2013, Journal of toxicology and environmental health. Part B, Critical reviews.

[21]  Langreth,et al.  New era of personalized medicine: targeting drugs for each unique genetic profile , 1999, The oncologist.

[22]  E. Shyong Tai,et al.  Nutrigenetics and Nutrigenomics: Viewpoints on the Current Status and Applications in Nutrition Research and Practice , 2011, Lifestyle Genomics.

[23]  Jing Zhao,et al.  Whole genome sequencing in support of wellness and health maintenance , 2013, Genome Medicine.

[24]  George M. Weinstock,et al.  Genomic approaches to studying the human microbiota , 2012, Nature.

[25]  J. P. Magalhães,et al.  Programmatic features of aging originating in development: aging mechanisms beyond molecular damage? , 2012 .

[26]  Jeffrey A Sparks,et al.  Communicating genetic risk information for common disorders in the era of genomic medicine. , 2013, Annual review of genomics and human genetics.

[27]  Feng Li,et al.  Glycobioinformatics: Current strategies and tools for data mining in MS‐based glycoproteomics , 2013, Proteomics.

[28]  A. Heck,et al.  Next-generation proteomics: towards an integrative view of proteome dynamics , 2012, Nature Reviews Genetics.

[29]  Michael H Weisman,et al.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. , 2006, The New England journal of medicine.

[30]  Barbara A. Wetmore,et al.  Toxicoproteomics: proteomics applied to toxicology and pathology. , 2004, Toxicologic pathology.

[31]  Nicholas Katsanis,et al.  Molecular genetic testing and the future of clinical genomics , 2013, Nature Reviews Genetics.

[32]  C. Rotimi,et al.  Pharmacogenomics, ancestry and clinical decision making for global populations , 2013, The Pharmacogenomics Journal.

[33]  Guido Erreygers,et al.  A dual Atkinson measure of socioeconomic inequality of health. , 2013, Health economics.

[34]  F A Leighton,et al.  The role of wildlife in emerging and re-emerging zoonoses. , 2004, Revue scientifique et technique.

[35]  I. Ajzen.  The theory of planned behavior , 1991 .

[36]  R. Godschalk,et al.  You are what you eat, and so are your children: the impact of micronutrients on the epigenetic programming of offspring , 2013, Cellular and Molecular Life Sciences.

[37]  M. Emmett,et al.  Integrative Biological Analysis For Neuropsychopharmacology , 2014, Neuropsychopharmacology.

[38]  R W Wilkinson,et al.  Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype , 2013, British Journal of Cancer.

[39]  M. Zanor,et al.  Metabolomics in Plants and Humans: Applications in the Prevention and Diagnosis of Diseases , 2013, BioMed research international.

[40]  C. Walsh,et al.  Somatic Mutation, Genomic Variation, and Neurological Disease , 2013, Science.

[41]  Jay R Hesselberth,et al.  Lives that introns lead after splicing , 2013, Wiley interdisciplinary reviews. RNA.

[42]  Gabriella Pravettoni,et al.  P5 medicine: a plus for a personalized approach to oncology , 2011, Nature Reviews Clinical Oncology.

[43]  D. Avard,et al.  Legal Liability and the Uncertain Nature of Risk Prediction: The Case of Breast Cancer Risk Prediction Models , 2012, Public Health Genomics.

[44]  D Gallagher,et al.  State-of-the-art measurements in human body composition: A moving frontier of clinical importance. , 2008, International journal of body composition research.

[45]  Gibson Wm.  Can Personalized Medicine Survive , 1971 .

[46]  Mihai Pop,et al.  Deep Sequencing of the Oral Microbiome Reveals Signatures of Periodontal Disease , 2012, PloS one.

[47]  H. Kitano.  Systems Biology: A Brief Overview , 2002, Science.

[48]  Mark T. W. Ebbert,et al.  PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers , 2012, BMC Medical Genomics.

[49]  Ian M. Fingerman,et al.  NCBI Epigenomics: What’s new for 2013 , 2012, Nucleic Acids Res..

[50]  Roberta B. Ness,et al.  Methods in Social Epidemiology Edited by J. Michael Oakes and Jay S. Kaufman , 2006 .

[51]  P. Gollwitzer,et al.  Implementation intentions and goal achievement: A meta-analysis of effects and processes , 2006 .

[52]  S. Ng,et al.  Geographical variability and environmental risk factors in inflammatory bowel disease , 2013, Gut.

[53]  Rui Chen,et al.  Promise of personalized omics to precision medicine , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[54]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[55]  M. Wagner.  Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traits. , 2013, Pharmacogenomics.

[56]  Rudi Balling,et al.  Revolutionizing medicine in the 21st century through systems approaches. , 2012, Biotechnology journal.

[57]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[58]  M. Snyder,et al.  iPOP goes the world: integrated personalized Omics profiling and the road toward improved health care. , 2013, Chemistry & biology.

[59]  Luigi Atzori,et al.  Metabolomics in the developing human being. , 2012, Pediatric clinics of North America.

[60]  Patricia K. Kuhl,et al.  Brain Responses to Words in 2-Year-Olds with Autism Predict Developmental Outcomes at Age 6 , 2013, PloS one.

[61]  Tomislav Horvat,et al.  Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies. , 2013, Current opinion in chemical biology.

[62]  Ferran Reverter,et al.  Transcriptomics: mRNA and alternative splicing , 2012, Journal of Neuroimmunology.

[63]  Alexander Heidrich,et al.  Automated Segmentation and Object Classification of CT Images: Application to In Vivo Molecular Imaging of Avian Embryos , 2013, Int. J. Biomed. Imaging.

[64]  S. Berger,et al.  Genome-wide epigenetics. , 2013, The Journal of investigative dermatology.

[65]  M. Conner,et al.  The Theory of Planned Behaviour , 2004 .

[66]  Simon Watkins,et al.  Personalized Exposure Assessment: Promising Approaches for Human Environmental Health Research , 2005, Environmental health perspectives.

[67]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[68]  David R Bassett,et al.  Device-based monitoring in physical activity and public health research , 2012, Physiological measurement.

[69]  Wylie Burke,et al.  Does genomic risk information motivate people to change their behavior? , 2009, Genome Medicine.

[70]  Jennifer M. Reingle,et al.  Do stressful events account for the link between socioeconomic status and mental health? , 2014, Journal of public health.

[71]  Mark P. Styczynski,et al.  Applications of metabolomics in cancer research , 2013, Journal of carcinogenesis.